AnodyneWiki

4-Methylaminorex

4-MAR
4-Methylaminorex
Molecular structure via molpic based on CDK
[]
Conformer structure via 3Dmol.js
Enable javascript to view conformer structure via 3Dmol.js
Physical properties
[]
176.21 g/mol [1]
1.2 [1]
Structural Identifiers
[]
C10H12N2[1]
4-methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-amine [1]
CC1C(OC(=N1)N)C2=CC=CC=C2 [1]
InChI=1S/C10H12N2O/c1-7-9(13-10(11)12-7)8-5-3-2-4-6-8/h2-7,9H,1H3,(H2,11,12) [1]
InChIKeyLJQBMYDFWFGESC-UHFFFAOYSA-N [1]
Pharmacokinetics[]
Elimination half-life10 – 19 hours

4-Methylaminorex (also known as 4,5-Dihydro-4-methyl-5-phenyl-2-oxazolamine, 4-Methylaminorex, 2-Oxazoline, 2-amino-4-methyl-5-phenyl-, 7PK6VC94OU, Dtxsid30860432, 2-Amino-4-methyl-5-phenyloxazoline, 4-methylaminorex, Dtxcid70206653, U4euh or 2-Amino-4-methyl-5-phenyl-2-oxazoline) is a stimulant substance of the aminorex class.

Chemistry

 []

4-Methylaminorex is a racemic mixture of the .

(1R,2R)-4-MethylaminorexGenerated by the Chemistry Development Kit (http://github.com/cdk)
(1S,2R)-4-MethylaminorexGenerated by the Chemistry Development Kit (http://github.com/cdk)
(1R,2S)-4-MethylaminorexGenerated by the Chemistry Development Kit (http://github.com/cdk)
(1S,2S)-4-MethylaminorexGenerated by the Chemistry Development Kit (http://github.com/cdk)
Stereoisomer enumberation with rdkit

Pharmacology

Metabolism

Subjective effects []

Experience reports []

 []

  • Australia: 4-Methylaminorex is a S9 substance.
  • Brazil: 4-Methylaminorex is a F2 substance.[2]
  • Canada: 4-Methylaminorex is a Schedule III substance.
  • United Kingdom: 4-Methylaminorex is a Class A substance.
  • United States: 4-Methylaminorex is a Schedule I under the "Controlled Substances Act (CSA)".
  • Germany: 4-Methylaminorex is a Anlage I substance.
  • United Nations: 4-Methylaminorex is a Schedule I drug under the "Convention on Psychotropic Substances 1971".

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 92196, 4,5-Dihydro-4-methyl-5-phenyl-2-oxazolamine. Accessed May 4, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/92196

  2. Anvisa. RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. July 24, 2023. Accessed May 4, 2026. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451